Genmab — Oktober 2018

[Bulder]

They also have the old one from last year in presurgical prostate. But again without pd1.

[peter12]

@EL You posted this link first time 28/8 but ok

[peter12]

What about this study ? https://www.clinicaltrialsregister.eu/ctr-search/search?query=nivolumab+daratumumab&dateFrom=2017-01-01&dateTo=2018-10-18

[Bulder]

Det første er MM. Det andet er et af BMS-studierne, som der skulle komme data fra om ikke så længe.

[E_L]

I just wanted to make sure you read it peter

[Bulder]

Samme som der her
https://www.clinicaltrials.gov/ct2/show/NCT03098550?term=daratumumab+nivolumab&rank=2

[peter12]

Remember its a dead cat

[E_L]

I don't want to be more optimistic as Jan, but i still have a bit of hope...

[Bulder]

No. only unconscious. And by the way a cat has 9 lives.

[peter12]

It must be breaking news

[E_L]

you mean because we are up a few dkk? shall we re-post another old article maybe?

[Bulder]

Try and repost the press-anouncement from the other day. It took me 2 hours to find out what the 16%-sentence meant. It seems it took the market 2 days.

[E_L]

haha, good idea

[peter12]

I mean: the cat was not dead ...;-)

[Bulder]

If you put your ear close enough, you can hear the breathing.

[peter12]

Maybe someone could say miaww Sorry I will stop now

[JStudsgaard]

Det ligner at AB har fået travlt med at lukke shorts nu. Gad vide om der er nyheder på vej

[Helge_LarsenPI-redaktør]

Aktieugebrevet har indtil videre ramt flot med deres køb af Genmab i går.

[saltpeter]

Er grædekonerne ud at synge til en begravelse i dag

[Helge_LarsenPI-redaktør]

Begrundelsen fra AU: "
Genmab er langsigtet i nedtrend, men på kort sigt kan kursfaldet have været for kraftigt. Der kan derfor blive tale om en forholdsvis kortsigtet investering."